Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512623001534 |
_version_ | 1827903536361373696 |
---|---|
author | Jonathan J. Park, PhD Eunsuh Park William E. Damsky, MD, PhD Matthew D. Vesely, MD, PhD |
author_facet | Jonathan J. Park, PhD Eunsuh Park William E. Damsky, MD, PhD Matthew D. Vesely, MD, PhD |
author_sort | Jonathan J. Park, PhD |
collection | DOAJ |
first_indexed | 2024-03-13T00:14:22Z |
format | Article |
id | doaj.art-4bfe430ae6354af59581442d2dcc3c46 |
institution | Directory Open Access Journal |
issn | 2352-5126 |
language | English |
last_indexed | 2024-03-13T00:14:22Z |
publishDate | 2023-07-01 |
publisher | Elsevier |
record_format | Article |
series | JAAD Case Reports |
spelling | doaj.art-4bfe430ae6354af59581442d2dcc3c462023-07-12T04:19:50ZengElsevierJAAD Case Reports2352-51262023-07-01371315Pembrolizumab-induced lichenoid dermatitis treated with dupilumabJonathan J. Park, PhD0Eunsuh Park1William E. Damsky, MD, PhD2Matthew D. Vesely, MD, PhD3Department of Genetics, Yale School of Medicine, New Haven, Connecticut; Department of Dermatology, Yale School of Medicine, New Haven, ConnecticutDepartment of Dermatology, Yale School of Medicine, New Haven, ConnecticutDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut; Department of Pathology, Yale School of Medicine, New Haven, ConnecticutDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut; Correspondence to: Matthew D. Vesely, MD, PhD, Department of Dermatology, Yale School of Medicine, 333 Cedar St, PO Box 208059, New Haven, CT 06510.http://www.sciencedirect.com/science/article/pii/S2352512623001534cancer immunotherapycutaneous immune related adverse eventsdupilumabimmune checkpointlichen planuslichenoid dermatitis |
spellingShingle | Jonathan J. Park, PhD Eunsuh Park William E. Damsky, MD, PhD Matthew D. Vesely, MD, PhD Pembrolizumab-induced lichenoid dermatitis treated with dupilumab JAAD Case Reports cancer immunotherapy cutaneous immune related adverse events dupilumab immune checkpoint lichen planus lichenoid dermatitis |
title | Pembrolizumab-induced lichenoid dermatitis treated with dupilumab |
title_full | Pembrolizumab-induced lichenoid dermatitis treated with dupilumab |
title_fullStr | Pembrolizumab-induced lichenoid dermatitis treated with dupilumab |
title_full_unstemmed | Pembrolizumab-induced lichenoid dermatitis treated with dupilumab |
title_short | Pembrolizumab-induced lichenoid dermatitis treated with dupilumab |
title_sort | pembrolizumab induced lichenoid dermatitis treated with dupilumab |
topic | cancer immunotherapy cutaneous immune related adverse events dupilumab immune checkpoint lichen planus lichenoid dermatitis |
url | http://www.sciencedirect.com/science/article/pii/S2352512623001534 |
work_keys_str_mv | AT jonathanjparkphd pembrolizumabinducedlichenoiddermatitistreatedwithdupilumab AT eunsuhpark pembrolizumabinducedlichenoiddermatitistreatedwithdupilumab AT williamedamskymdphd pembrolizumabinducedlichenoiddermatitistreatedwithdupilumab AT matthewdveselymdphd pembrolizumabinducedlichenoiddermatitistreatedwithdupilumab |